Gerrit Draisma

4.8k total citations · 2 hit papers
39 papers, 3.2k citations indexed

About

Gerrit Draisma is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Gerrit Draisma has authored 39 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Gerrit Draisma's work include Global Cancer Incidence and Screening (22 papers), Colorectal Cancer Screening and Detection (18 papers) and Prostate Cancer Diagnosis and Treatment (11 papers). Gerrit Draisma is often cited by papers focused on Global Cancer Incidence and Screening (22 papers), Colorectal Cancer Screening and Detection (18 papers) and Prostate Cancer Diagnosis and Treatment (11 papers). Gerrit Draisma collaborates with scholars based in Netherlands, United States and Myanmar. Gerrit Draisma's co-authors include Harry J. de Koning, Rob Boer, Suzie J. Otto, Ronald Damhuis, F.H. Schröder, Eveline A.M. Heijnsdijk, Alex Tsodikov, Ruth Etzioni, Angela B. Mariotto and Eric J. Feuer and has published in prestigious journals such as Annals of Internal Medicine, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Gerrit Draisma

39 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer

2003 771 citations Gerrit Draisma, Rob Boer et al. JNCI Journal of the National Cancer Institute profile →
Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context

2009 578 citations Gerrit Draisma, Ruth Etzioni et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerrit Draisma Netherlands	24	1.8k	1.4k	438	411	314	39	3.2k
Roman Gulati United States	34	2.3k 1.2×	1.6k 1.1×	394 0.9×	662 1.6×	304 1.0×	128	3.6k
Yu-Ning Wong United States	21	2.2k 1.2×	954 0.7×	521 1.2×	810 2.0×	662 2.1×	30	3.2k
Timothy N. Showalter United States	31	1.6k 0.9×	707 0.5×	664 1.5×	446 1.1×	810 2.6×	215	3.5k
G.R. Kerr United Kingdom	31	1.1k 0.6×	1.1k 0.8×	1.2k 2.6×	642 1.6×	346 1.1×	97	3.2k
Steven J. Lemery United States	26	852 0.5×	1.8k 1.3×	482 1.1×	782 1.9×	156 0.5×	65	3.3k
Pascal Piedbois France	31	1.2k 0.7×	2.5k 1.7×	1.0k 2.3×	359 0.9×	225 0.7×	101	3.7k
James J. Dignam United States	24	1.0k 0.6×	1.8k 1.2×	353 0.8×	1.2k 2.9×	270 0.9×	55	3.5k
Ronald Damhuis Netherlands	31	1.9k 1.0×	1.9k 1.3×	810 1.8×	344 0.8×	205 0.7×	118	3.9k
Kyounghwa Bae United States	28	3.4k 1.9×	980 0.7×	438 1.0×	334 0.8×	477 1.5×	46	4.2k
Marco Bonetti Italy	22	697 0.4×	1.0k 0.7×	303 0.7×	660 1.6×	95 0.3×	68	2.4k

Countries citing papers authored by Gerrit Draisma

Since Specialization

Citations

This map shows the geographic impact of Gerrit Draisma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerrit Draisma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerrit Draisma more than expected).

Fields of papers citing papers by Gerrit Draisma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerrit Draisma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerrit Draisma. The network helps show where Gerrit Draisma may publish in the future.

Co-authorship network of co-authors of Gerrit Draisma

This figure shows the co-authorship network connecting the top 25 collaborators of Gerrit Draisma. A scholar is included among the top collaborators of Gerrit Draisma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerrit Draisma. Gerrit Draisma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Etzioni, Ruth, Roman Gulati, Alex Tsodikov, et al.. (2012). The prostate cancer conundrum revisited. Cancer. 118(23). 5955–5963. 107 indexed citations

Wever, Elisabeth M., Gerrit Draisma, Eveline A.M. Heijnsdijk, & Harry J. de Koning. (2011). How Does Early Detection by Screening Affect Disease Progression?. Medical Decision Making. 31(4). 550–558. 33 indexed citations

Gulati, Roman, Elisabeth M. Wever, Alex Tsodikov, et al.. (2011). What If I Don't Treat My PSA-Detected Prostate Cancer? Answers from Three Natural History Models. Cancer Epidemiology Biomarkers & Prevention. 20(5). 740–750. 34 indexed citations

Ravesteyn, Nicolien T. van, Eveline A.M. Heijnsdijk, Gerrit Draisma, & Harry J. de Koning. (2011). Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals. British Journal of Cancer. 105(7). 1082–1088. 10 indexed citations

Gelder, Rianne de, Eveline A.M. Heijnsdijk, Nicolien T. van Ravesteyn, et al.. (2011). Interpreting Overdiagnosis Estimates in Population-based Mammography Screening. Epidemiologic Reviews. 33(1). 111–121. 147 indexed citations

Mandelblatt, Jeanne S., Kathleen A. Cronin, Stephanie Bailey, et al.. (2010). Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network. Effects of mammography screening under different screening schedules: Model estimates of potential benefits and harms (Annals of Internal Medicine (2009) 151, (738-747)). Annals of Internal Medicine. 152(2). 24 indexed citations

Wever, Elisabeth M., Gerrit Draisma, Eveline A.M. Heijnsdijk, et al.. (2010). Prostate-Specific Antigen Screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer–Rotterdam. JNCI Journal of the National Cancer Institute. 102(5). 352–355. 40 indexed citations

Heijnsdijk, Eveline A.M., et al.. (2009). Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer. British Journal of Cancer. 101(11). 1833–1838. 127 indexed citations

Gelder, Rianne de, Jean‐Luc Bulliard, Chris de Wolf, et al.. (2008). Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland. European Journal of Cancer. 45(1). 127–138. 69 indexed citations

10.

Draisma, Gerrit, et al.. (2008). Breast Cancer Screening Policies in Developing Countries: A Cost-effectiveness Analysis for India. JNCI Journal of the National Cancer Institute. 100(18). 1290–1300. 128 indexed citations

11.

Gelder, Rianne de, Madeleine M.A. Tilanus‐Linthorst, Carina C. M. Bartels, et al.. (2008). Breast cancer screening: Evidence for false reassurance?. International Journal of Cancer. 123(3). 680–686. 17 indexed citations

12.

Groenewoud, Johanna H., J.D.M. Otten, Jacques Fracheboud, et al.. (2006). Cost-effectiveness of different reading and referral strategies in mammography screening in the Netherlands. Breast Cancer Research and Treatment. 102(2). 211–218. 23 indexed citations

13.

Iersel, Carola A. van, Harry J. de Koning, Gerrit Draisma, et al.. (2006). Risk‐based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch‐Belgian randomised lung cancer multi‐slice CT screening trial (NELSON). International Journal of Cancer. 120(4). 868–874. 376 indexed citations

14.

Draisma, Gerrit, Renske Postma, Fritz H. Schröder, Theodorus van der Kwast, & Harry J. de Koning. (2006). Gleason score, age and screening: Modeling dedifferentiation in prostate cancer. International Journal of Cancer. 119(10). 2366–2371. 59 indexed citations

15.

Fracheboud, Jacques, Johanna H. Groenewoud, Rob Boer, et al.. (2005). Seventy‐five years is an appropriate upper age limit for population‐based mammography screening. International Journal of Cancer. 118(8). 2020–2025. 33 indexed citations

16.

Koning, Harry J. de, et al.. (2005). Overdiagnosis and overtreatment of breast cancer: Microsimulation modelling estimates based on observed screen and clinical data. Breast Cancer Research. 8(1). 202–202. 39 indexed citations

17.

Rijnsburger, Adriana J., G.J. van Oortmarssen, Rob Boer, et al.. (2004). Mammography benefit in the Canadian National Breast Screening Study‐2: A model evaluation. International Journal of Cancer. 110(5). 756–762. 41 indexed citations

18.

Draisma, Gerrit, et al.. (2004). Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality. British Journal of Cancer. 91(2). 242–247. 65 indexed citations

19.

Draisma, Gerrit, Rob Boer, Suzie J. Otto, et al.. (2003). Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer. JNCI Journal of the National Cancer Institute. 95(12). 868–878. 771 indexed citations breakdown →

20.

Draisma, Gerrit, Holger Drees, Ana Ferreira, & Laurens de Haan. (2001). Tail dependence in independence. Data Archiving and Networked Services (DANS). 2001014. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact